Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | MEMANTINE HYDROCHLORIDE |
| Generic name | MEMANTINE HYDROCHLORIDE |
| Active ingredient(s) | MEMANTINE HYDROCHLORIDE |
| Distributed by / for | Major Pharmaceuticals, Indianapolis, IN 46268 |
| NDC | 0904-6734-61 |
| Full product label | Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268, NDC 0904-6734-61 |
| Recalling firm | The Harvard Drug Group LLC |
| Distribution | US Nationwide. |
| Quantity | N/A |
| Recall initiated | 2026-03-24 |
| Report date | 2026-04-22 |
| Recall completed | — |
| Recall number | D-0485-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Dublin OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗